EP2780303A1 - Separation technique, photo-oxidation of organic substrates, and photo catalysts - Google Patents
Separation technique, photo-oxidation of organic substrates, and photo catalystsInfo
- Publication number
- EP2780303A1 EP2780303A1 EP12812308.0A EP12812308A EP2780303A1 EP 2780303 A1 EP2780303 A1 EP 2780303A1 EP 12812308 A EP12812308 A EP 12812308A EP 2780303 A1 EP2780303 A1 EP 2780303A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- photocatalyst
- mixture
- fluorous solvent
- organic
- supercritical fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000011941 photocatalyst Substances 0.000 title claims abstract description 103
- 239000000758 substrate Substances 0.000 title claims abstract description 43
- 238000007539 photo-oxidation reaction Methods 0.000 title claims description 23
- 238000000926 separation method Methods 0.000 title description 7
- 239000002904 solvent Substances 0.000 claims abstract description 73
- 239000000203 mixture Substances 0.000 claims abstract description 54
- 238000000034 method Methods 0.000 claims abstract description 52
- 239000012530 fluid Substances 0.000 claims abstract description 46
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000007788 liquid Substances 0.000 claims abstract description 13
- 239000001301 oxygen Substances 0.000 claims abstract description 13
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 13
- 239000007792 gaseous phase Substances 0.000 claims abstract description 11
- 230000001678 irradiating effect Effects 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 50
- 239000012071 phase Substances 0.000 claims description 47
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 37
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 claims description 31
- 239000001569 carbon dioxide Substances 0.000 claims description 25
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 claims description 14
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 claims description 14
- 235000000484 citronellol Nutrition 0.000 claims description 14
- 238000007124 photooxygenation reaction Methods 0.000 claims description 11
- YHQGMYUVUMAZJR-UHFFFAOYSA-N α-terpinene Chemical compound CC(C)C1=CC=C(C)CC1 YHQGMYUVUMAZJR-UHFFFAOYSA-N 0.000 claims description 11
- 238000006555 catalytic reaction Methods 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 7
- URJIJZCEKHSLHA-UHFFFAOYSA-N 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecane-1-thiol Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)CCS URJIJZCEKHSLHA-UHFFFAOYSA-N 0.000 claims description 6
- 229920001774 Perfluoroether Polymers 0.000 claims description 6
- VJEVAXUMNMFKDT-UHFFFAOYSA-N 5,10,15,20-tetrakis(2,3,4,5,6-pentafluorophenyl)-21,23-dihydroporphyrin Chemical compound Fc1c(F)c(F)c(c(F)c1F)-c1c2ccc(n2)c(-c2c(F)c(F)c(F)c(F)c2F)c2ccc([nH]2)c(-c2c(F)c(F)c(F)c(F)c2F)c2ccc(n2)c(-c2c(F)c(F)c(F)c(F)c2F)c2ccc1[nH]2 VJEVAXUMNMFKDT-UHFFFAOYSA-N 0.000 claims description 5
- 230000000078 anti-malarial effect Effects 0.000 claims description 5
- 239000003430 antimalarial agent Substances 0.000 claims description 5
- -1 bipyrazine Chemical compound 0.000 claims description 5
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 claims description 4
- 150000004032 porphyrins Chemical class 0.000 claims description 4
- 150000004901 trioxanes Chemical class 0.000 claims description 4
- HKOAFLAGUQUJQG-UHFFFAOYSA-N 2-pyrimidin-2-ylpyrimidine Chemical compound N1=CC=CN=C1C1=NC=CC=N1 HKOAFLAGUQUJQG-UHFFFAOYSA-N 0.000 claims description 3
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 claims description 3
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 claims description 3
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical compound C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 claims description 3
- BHPNXACHQYJJJS-UHFFFAOYSA-N bacteriochlorin Chemical compound N1C(C=C2N=C(C=C3NC(=C4)C=C3)CC2)=CC=C1C=C1CCC4=N1 BHPNXACHQYJJJS-UHFFFAOYSA-N 0.000 claims description 3
- SURLGNKAQXKNSP-DBLYXWCISA-N chlorin Chemical compound C\1=C/2\N/C(=C\C3=N/C(=C\C=4NC(/C=C\5/C=CC/1=N/5)=CC=4)/C=C3)/CC\2 SURLGNKAQXKNSP-DBLYXWCISA-N 0.000 claims description 3
- 229910003472 fullerene Inorganic materials 0.000 claims description 3
- 150000002500 ions Chemical class 0.000 claims description 3
- 229960000907 methylthioninium chloride Drugs 0.000 claims description 3
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 claims description 3
- 229930187593 rose bengal Natural products 0.000 claims description 3
- AZJPTIGZZTZIDR-UHFFFAOYSA-L rose bengal Chemical compound [K+].[K+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 AZJPTIGZZTZIDR-UHFFFAOYSA-L 0.000 claims description 3
- 229940081623 rose bengal Drugs 0.000 claims description 3
- STRXNPAVPKGJQR-UHFFFAOYSA-N rose bengal A Natural products O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 STRXNPAVPKGJQR-UHFFFAOYSA-N 0.000 claims description 3
- WSTYNZDAOAEEKG-UHFFFAOYSA-N Mayol Natural products CC1=C(O)C(=O)C=C2C(CCC3(C4CC(C(CC4(CCC33C)C)=O)C)C)(C)C3=CC=C21 WSTYNZDAOAEEKG-UHFFFAOYSA-N 0.000 claims description 2
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 claims description 2
- 150000001336 alkenes Chemical class 0.000 claims description 2
- 150000004808 allyl alcohols Chemical class 0.000 claims description 2
- 150000001728 carbonyl compounds Chemical class 0.000 claims description 2
- 150000001993 dienes Chemical class 0.000 claims description 2
- 150000002240 furans Chemical class 0.000 claims description 2
- 239000002815 homogeneous catalyst Substances 0.000 claims description 2
- 229930195735 unsaturated hydrocarbon Natural products 0.000 claims description 2
- 239000000047 product Substances 0.000 description 41
- HHBBIOLEJRWIGU-UHFFFAOYSA-N 4-ethoxy-1,1,1,2,2,3,3,4,5,6,6,6-dodecafluoro-5-(trifluoromethyl)hexane Chemical compound CCOC(F)(C(F)(C(F)(F)F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)F HHBBIOLEJRWIGU-UHFFFAOYSA-N 0.000 description 33
- 238000006243 chemical reaction Methods 0.000 description 21
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000012025 fluorinating agent Substances 0.000 description 5
- 231100000489 sensitizer Toxicity 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 4
- 229960002521 artenimol Drugs 0.000 description 4
- BJDCWCLMFKKGEE-ISOSDAIHSA-N artenimol Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2O[C@H](O)[C@@H]4C BJDCWCLMFKKGEE-ISOSDAIHSA-N 0.000 description 4
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 description 4
- 238000005191 phase separation Methods 0.000 description 4
- 230000007704 transition Effects 0.000 description 4
- OAVATZKRRRODNT-UHFFFAOYSA-N [4-methyl-3,5-bis(1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluorohexyl)phenyl]methanamine Chemical compound CC1=C(C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C=C(CN)C=C1C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F OAVATZKRRRODNT-UHFFFAOYSA-N 0.000 description 3
- 239000008186 active pharmaceutical agent Substances 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- UENWRTRMUIOCKN-UHFFFAOYSA-N benzyl thiol Chemical compound SCC1=CC=CC=C1 UENWRTRMUIOCKN-UHFFFAOYSA-N 0.000 description 3
- 230000002051 biphasic effect Effects 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- QIROQPWSJUXOJC-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5,5,6-undecafluoro-6-(trifluoromethyl)cyclohexane Chemical compound FC(F)(F)C1(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C1(F)F QIROQPWSJUXOJC-UHFFFAOYSA-N 0.000 description 2
- 238000004293 19F NMR spectroscopy Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- BRJULSXZDFYSPG-MSMJXPJBSA-N CC(C)(N)NC(=O)C[C@H]1CC[C@]2(CC1)OOC1(O2)[C@H]2CC3CC(C2)C[C@H]1C3 Chemical compound CC(C)(N)NC(=O)C[C@H]1CC[C@]2(CC1)OOC1(O2)[C@H]2CC3CC(C2)C[C@H]1C3 BRJULSXZDFYSPG-MSMJXPJBSA-N 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- UVNHKOOJXSALHN-ILQPJIFQSA-N artelinic acid Chemical compound O([C@@H]1[C@H](C)[C@@H]2CC[C@H]([C@@H]3CC[C@]4(C)O[C@H]([C@]23OO4)O1)C)CC1=CC=C(C(O)=O)C=C1 UVNHKOOJXSALHN-ILQPJIFQSA-N 0.000 description 2
- 229960004191 artemisinin Drugs 0.000 description 2
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 description 2
- 229930101531 artemisinin Natural products 0.000 description 2
- 229960002970 artemotil Drugs 0.000 description 2
- NLYNIRQVMRLPIQ-XQLAAWPRSA-N artemotil Chemical compound C1C[C@H]2[C@H](C)CC[C@H]3[C@@H](C)[C@@H](OCC)O[C@H]4[C@]32OO[C@@]1(C)O4 NLYNIRQVMRLPIQ-XQLAAWPRSA-N 0.000 description 2
- 229950007854 arterolane Drugs 0.000 description 2
- 229960004991 artesunate Drugs 0.000 description 2
- FIHJKUPKCHIPAT-AHIGJZGOSA-N artesunate Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2O[C@@H](OC(=O)CCC(O)=O)[C@@H]4C FIHJKUPKCHIPAT-AHIGJZGOSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 2
- 229930016266 dihydroartemisinin Natural products 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229960004624 perflexane Drugs 0.000 description 2
- 229950011087 perflunafene Drugs 0.000 description 2
- UWEYRJFJVCLAGH-IJWZVTFUSA-N perfluorodecalin Chemical compound FC1(F)C(F)(F)C(F)(F)C(F)(F)[C@@]2(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)[C@@]21F UWEYRJFJVCLAGH-IJWZVTFUSA-N 0.000 description 2
- ZJIJAJXFLBMLCK-UHFFFAOYSA-N perfluorohexane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F ZJIJAJXFLBMLCK-UHFFFAOYSA-N 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000013341 scale-up Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- KQBSGRWMSNFIPG-UHFFFAOYSA-N trioxane Chemical compound C1COOOC1 KQBSGRWMSNFIPG-UHFFFAOYSA-N 0.000 description 2
- XEEQGYMUWCZPDN-DOMZBBRYSA-N (-)-(11S,2'R)-erythro-mefloquine Chemical compound C([C@@H]1[C@@H](O)C=2C3=CC=CC(=C3N=C(C=2)C(F)(F)F)C(F)(F)F)CCCN1 XEEQGYMUWCZPDN-DOMZBBRYSA-N 0.000 description 1
- OKIYQFLILPKULA-UHFFFAOYSA-N 1,1,1,2,2,3,3,4,4-nonafluoro-4-methoxybutane Chemical compound COC(F)(F)C(F)(F)C(F)(F)C(F)(F)F OKIYQFLILPKULA-UHFFFAOYSA-N 0.000 description 1
- OVCDSSHSILBFBN-UHFFFAOYSA-N Amodiaquine Chemical compound C1=C(O)C(CN(CC)CC)=CC(NC=2C3=CC=C(Cl)C=C3N=CC=2)=C1 OVCDSSHSILBFBN-UHFFFAOYSA-N 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 229960001444 amodiaquine Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- DYLGFOYVTXJFJP-MYYYXRDXSA-N lumefantrine Chemical compound C12=CC(Cl)=CC=C2C=2C(C(O)CN(CCCC)CCCC)=CC(Cl)=CC=2\C1=C/C1=CC=C(Cl)C=C1 DYLGFOYVTXJFJP-MYYYXRDXSA-N 0.000 description 1
- 229960004985 lumefantrine Drugs 0.000 description 1
- 229960001962 mefloquine Drugs 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 230000001706 oxygenating effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000007146 photocatalysis Methods 0.000 description 1
- 230000001699 photocatalysis Effects 0.000 description 1
- UCRHFBCYFMIWHC-UHFFFAOYSA-N piperaquine Chemical compound ClC1=CC=C2C(N3CCN(CC3)CCCN3CCN(CC3)C=3C4=CC=C(C=C4N=CC=3)Cl)=CC=NC2=C1 UCRHFBCYFMIWHC-UHFFFAOYSA-N 0.000 description 1
- 229950006717 piperaquine Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/16—Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation
- C07C51/21—Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation with molecular oxygen
- C07C51/25—Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation with molecular oxygen of unsaturated compounds containing no six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B41/00—Formation or introduction of functional groups containing oxygen
- C07B41/14—Formation or introduction of functional groups containing oxygen of peroxy of hydroperoxy groups
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
- B01J19/12—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor employing electromagnetic waves
- B01J19/122—Incoherent waves
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C407/00—Preparation of peroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
Definitions
- the present invention relates to the photo-oxidation of organic substrates and, in particular, continuous photo-oxidation with singlet oxygen in a supercritical fluid, preferably supercritical carbon dioxide, by use of fluorous biphasic catalysis.
- the invention relates to methods of photo -oxidising organic substrates, separating photocatalysts from organic products, mixtures for use in photo-oxidation and methods of manufacturing photocatalysts, new photo-catalysts, and new uses thereof.
- the invention sets out to address these and other problems with the prior art.
- the present invention provides a method for photo -oxidising an organic substrate to form an organic product.
- the method is a method for photo- oxygenating an organic substrate to form an organic product.
- the method comprises the steps of: a) mixing oxygen, a supercritical fluid, a photocatalyst, a fluorous solvent and an organic substrate to form a mixture; and, preferably, b) irradiating the mixture to form an organic product.
- the supercritical fluid is supercritical carbon dioxide.
- the method further comprises the step of reducing the mixture pressure to below the critical pressure of the supercritical fluid to form a gaseous phase.
- the fluorous solvent is liquid at the critical point of the supercritical fluid.
- the fluorous solvent is liquid at pressures at or below the critical pressure of the supercritical fluid.
- the fluorous solvent is liquid at standard temperature and pressure (i.e. 20 °C and an absolute pressure of 101.325 kPa).
- the gaseous phase is gaseous carbon dioxide.
- the pressure is lowered below the critical pressure of carbon dioxide, preferably to atmospheric pressure (i.e.
- the temperature will be kept constant, although it is possible for the temperature to be raised or, more preferably, lowered, typically below the critical temperature of the supercritical fluid, typically to below the critical temperature of carbon dioxide, typically to room temperature (i.e. 20 °C).
- the phase separation of the supercritical fluid and fluorous solvent is controlled by varying the pressure. Controlling the phase separation of the supercritical fluid and fluorous solvent using pressure, rather than relying on temperature modulated extraction techniques, is preferable because it is safer for this type of compound.
- the method preferably comprises the step of separating the gaseous phase and fluorous solvent; typically, gaseous carbon dioxide and liquid fluorous solvent. This is typically followed by the step of separating the fluorous solvent from the organic product.
- fluorous solvent typically, gaseous carbon dioxide and liquid fluorous solvent.
- the organic product and liquid fluorous solvent are substantially immiscible and/or insoluble.
- organic product and liquid fluorous solvent separate into distinct phases, preferably distinct liquid phases.
- the fluorous solvent is denser than the organic product.
- the organic product is more polar than the fluorous solvent.
- the organic product may be diluted during the separation step using a non-fluorous solvent in order to lower the viscosity of the organic product.
- Suitable non- fluorous solvents include methanol.
- the fluorous solvent and organic product may be agitated in order to expedite separation, for instance by using an ultrasonic bath.
- the photocatalyst is soluble in the fluorous solvent.
- the photocatalyst is preferentially soluble in the fluorous solvent over the organic product.
- the fluorous solvent when the fluorous solvent is separated from the organic product, the fluorous solvent comprises photocatalyst from the mixture, preferably a majority of the photocatalyst from the mixture, preferably at least about 70 % of the photocatalyst from the mixture, preferably at least about 80 % of the photocatalyst from the mixture, more preferably substantially all of the photocatalyst.
- the photocatalyst, organic substrate, organic product, and fluorous solvent are soluble in the supercritical fluid, preferably supercritical carbon dioxide.
- the fluorous solvent and the photocatalyst are recycled. This has the advantage of greatly reducing the amount of photocatalyst required to provide a given amount of organic product.
- any fluorous solvent lost when removing the gaseous carbon dioxide may be replaced.
- substantially all of the fluorous solvent is recovered from the gaseous carbon dioxide, e.g. by distillation.
- the mixture is single phase, preferably a clear single phase.
- the mixing step and/or irradiating steps are conducted at a pressure sufficient for the mixture to form a single phase, preferably a clear single phase.
- the pressure is at least about 7.38 MPa; preferably, at least about 14 MPa; more preferably, at least about 16 MPa.
- the skilled person would be able to select an appropriate preferred pressure by observing when the mixture transitions from a cloudy to a clear single phase and selecting a pressure above that of the transition.
- the pressure will be above the critical pressure of the supercritical fluid.
- the mixing and/or irradiating steps are conducted at a temperature above the critical temperature of the supercritical fluid.
- the temperature of the mixture is at least about 31.1 °C; preferably, at least about 40 °C; preferably, from about 31.1 °C to about 70 °C; preferably, from about 40 °C to about 60 °C, preferably about 55 °C.
- the photocatalyst is fluorophilic, preferably a fluorinated photocatalyst.
- Fluorinated photocatalysts are preferred as they show good solubility in supercritical fluids, in particular carbon dioxide, and fluorous solvents.
- Known photocatalysts may be fluorinated by reacting them with a fluorinating agent, for instance with a with a fluoroalkanethiol, preferably a perfluoroalkanethiol, such as 3 ,3 ,4,4,5 ,5 ,6,6,7,7,8,8,9,9, 10, 10, 10-heptadecafluorodecane- 1 -thiol.
- fluorinating agents include perfluoroalkaneamines and amine and thiol benzyl subsititued perfluoroalkanes such as 3-perfluorooctylpropylamine, 4-methyl-3,5- bis(perfluorohexyl)benzylthiol, 4-methyl-3,5-bis(perfluorohexyl)benzylamine.
- the photocatalyst is a fluorinated derivative of a photocatalyst; examples preferably include organic non-polar sensitisers such as porphyrin, chlorin, bacteriochlorin, phthalocyanine, or fullerene (C 6 o).
- organic non-polar sensitisers such as porphyrin, chlorin, bacteriochlorin, phthalocyanine, or fullerene (C 6 o).
- Other embodiments use polar sensitisers with appropariate fluorinated ions, suitable examples include methylene blue, rose Bengal, Ru 2+ L 3 complexes, where L is any combination of bipyridine, bipyrazine, and 2,2- bipyrimidine and derivatives thereof.
- the photocatalyst is selected from the group consisting of non-polar organic sensitisers, typically porphyrins.
- the a photocatalyst is
- a, b, c and d > 1, preferably, from 1 to 16, more preferably, from 2 to 10, more preferably, 7; and m, n, o, p >1, preferably, 1.
- a particularly preferred photocatalyst is
- the organic substrate is selected from the group consisting of unsaturated hydrocarbons, preferably dienes (particularly alpha-terpinene), furans, highly substituted olefins (particularly tetra or tri substituted e.g. citronellol), allylic alcohols, carbonyl compounds.
- unsaturated hydrocarbons preferably dienes (particularly alpha-terpinene), furans, highly substituted olefins (particularly tetra or tri substituted e.g. citronellol), allylic alcohols, carbonyl compounds.
- the fluorous solvent is selected from the group consisting of fluorocarbons and fluoroethers and combinations thereof, preferably perfluorocarbons, hydro fluorocarbons, perfluoroaromatics, perfluorethers, and hydro fluoroethers.
- Suitable perfluorocarbons include perfluorohexane, perfluoromethylcyclohexane, or perfluorodecalin.
- HFEs hydro fluoroethers
- HFE-7100 and HFE-7500 both sold by 3M.
- the invention provides an organic product manufactured using any of the methods of the first aspect.
- the invention provides the use of the method of the first aspect in the manufacture of trioxane, and derivatives thereof, primarily hydroxyl substituted hydroperoxides preferentially possessing a hydroxyl group located 3-4 bonds from the peroxide, possibly 2-5 bonds.
- the invention provides a mixture comprising an organic substrate and/or an organic product; optionally oxygen; a supercritical fluid; a photocatalyst and a fluorous solvent.
- the supercritical fluid is supercritical carbon dioxide.
- the mixture will not comprise oxygen.
- the mixture is single phase; preferably, the mixture is a clear single phase.
- the mixture will transition from a multi-phase to a single-phase mixture by increasing the pressure of the mixture.
- the pressure is at least about 7.39 MPa; preferably, at least about 14 MPa; more preferably, at least about 16 MPa.
- the skilled person would be able to select an appropriate preferred pressure by observing when the mixture transitions from a cloudy to a clear single phase.
- the temperature of the mixture is at least about 31.1 °C; preferably, at least about 40 °C; preferably, from about 31.1 °C to about 70 °C; preferably, from about 40 °C to about 60 °C, preferably about 55 °C.
- the invention also provides the use of the mixture of the fourth aspect in the photo- oxidation, preferably photo-oxygenation, of an organic substrate.
- the invention also provides the use of the mixture of the fourth aspect in a homogenous catalysis photo-oxidation reaction; preferably a homogenous catalysis photo-oxygenation reaction; preferably, wherein the photocatalyst is recycled.
- photocatalysts, fluorous solvents, organic products and organic substrates described in embodiments of the first aspect are also applicable to the second, third and fourth aspects of the invention.
- the present invention provides a photocatalyst
- a particularly preferred photocatalyst is
- the invention also provides the use of the photocatalyst of the fifth aspect in homogenous catalysis.
- the invention further provides the use of the photocatalyst of the fifth aspect of the invention in a photo -oxidation reaction, preferably, a photo-oxygenation reaction; preferably continuous homogenous catalysis photo-oxidation reaction, more preferably in a continuous homogenous catalysis photo-oxygenation reaction.
- the invention also provides the use of the photocatalyst of the fifth aspect of the invention in any of the methods of the first aspect of the invention.
- the invention provides a method for manufacturing a photocatalyst according to the fifth aspect comprising the step of reacting 5,10,15,20- tetrakis(pentafluorophenyl)porphyrin (TPFPP) with a fluroalkanethiol, preferably, a perfluoroalkanethiol, preferably, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- heptadecafluorodecane-1 -thiol.
- a fluroalkanethiol preferably, a perfluoroalkanethiol, preferably, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- heptadecafluorodecane-1 -thiol.
- a mixture of different fluroalkanethiols may be used.
- fluorinating agents include perfluoroalkaneamines and amine and thiol benzyl subsititued perfluoroalkanes such as 3- perfluorooctylpropylamine, 4-methyl-3,5-bis(perfluorohexyl)benzylthiol, 4-methyl-3,5- bis(perfluorohexyl)benzylamine.
- the invention provides a method for manufacturing a photocatalyst for use in the homogenous catalysis of an organic substrate comprising the steps of a) selecting a fluorous solvent; b) selecting a supercritical fluid; c) selecting a photocatalyst; and d) fluorinating the photocatalyst to such an extent that the fluorinated photocatalyst is soluble in both the fluorous solvent and the supercritical fluid.
- the supercritical fluid is supercritical carbon dioxide.
- the fluorous solvents, photocatalysts and organic substrates may be selected from any of those listed in relation to the previous aspects and embodiments of the invention.
- the fluorinated photocatalyst is preferentially soluble in the fluorous solvent over the photo-oxidised organic substrate.
- the invention also provides a photocatalyst manufactured according to the seventh aspect of the invention, and the use of said photocatalyst in the photo -oxidation of an organic substrate.
- the invention provides a method for separating a photocatalyst from an organic product comprising the steps of: a) providing a mixture comprising a supercritical fluid; an organic product; a fluorous solvent; a photocatalyst; and optionally an organic substrate and optionally oxygen; wherein the organic product, fluorous solvent, photocatalyst and optional organic substrate and optional oxygen are dissolved in the supercritical fluid; and b) reducing the pressure of the mixture to a pressure below the critical pressure of the supercritical fluid in order to form a gaseous phase.
- photo -oxidation includes photo- oxygenation.
- Fig. 1 is a series of photographs showing the phase behaviour of a a-terpinene (6.4 mmol) + HFE-7500 (4.0 mmol) + C0 2 (0.24 mol) + N 2 (12.5 mmol) system at 55 °C under different pressure.
- Fig. 2 is a series of photographs showing the phase behaviour a citronellol (5.5 mmol) + HFE-7500 (3.9 mmol) + C0 2 (0.24 mol) + N 2 (12.5 mmol) system at 55 °C under different pressure.
- Fig. 3 is a graph showing conversion / pressure for a a-terpinene (6.4 mmol) + HFE-7500 (4.0 mmol) + C0 2 (0.24 mol) + N 2 (12.5 mmol) system at 55 °C under different pressure.
- Fig. 4 is a graph showing conversion / pressure for a citronellol (5.5 mmol) + HFE-7500 (3.9 mmol) + C0 2 (0.24 mol) + N 2 (12.5 mmol) system at 55 °C.
- Fig. 5 is a schematic of the continuous recycle experiment equipment.
- the present invention provides a method for the photo-oxidation of an organic substrate to an organic product comprising the steps of: a) mixing oxygen, a supercritical fluid, a photocatalyst, a fluorous solvent and an organic substrate to form a mixture; and, preferably, b) irradiating the mixture to form an organic product.
- the supercritical fluid is supercritical carbon dioxide.
- Supercritical fluid is the fluid state of any substance at a temperature and pressure above its critical point, where distinct liquid and gas phases do not exist.
- supercritical fluids can effuse through solids like a gas, and dissolve materials like a liquid.
- Suitable supercritical fluids for use in the invention include supercritical methane, ethane and carbon dioxide.
- Supercritical carbon dioxide is a fluid state of carbon dioxide where it is held at or above its critical temperature and critical pressure. Specifically, carbon dioxide behaves as a supercritical fluid above its critical temperature of 31.1 °C and critical pressure of 7.38 MPa.
- photo-oxidation is understood to be a light-induced oxidation reaction.
- Photo -oxidation includes photo-oxygenation.
- photo-oxygenation is understood to be a light-induced oxidation reaction in which molecular oxygen is incorporated into organic substrate.
- the photo-oxygenation reactions of the invention use singlet oxygen ( 1 0 2 ).
- Photocatalyst is understood to mean a catalyst which accelerates a photo-oxidation, preferably photo-oxygenation, reaction.
- the photocatalyst is soluble in the fluorous solvent.
- the photocatalyst is preferentially soluble in the liquid fluorous solvent over the organic product.
- the photocatalyst is soluble in supercritical carbon dioxide. Relative solubility should be measured at standard temperature and pressure.
- the photocatalyst is fluorophilic.
- the photocatalyst is fluorinated. Fluorinated photocatalysts are preferred as they show good solubility in supercritical carbon dioxide and fluorous solvents.
- Known photocatalysts may be fluorinated by reacting them with a fluorinating agent, for instance a with a fluoroalkanethiol, preferably a perfluoroalkanethiol, such as 3,3,4,4,5,5,6,6,7,7,8,8,9,9, 10,10, 10-heptadecafluorodecane- 1 -thiol.
- a fluorinating agent for instance a with a fluoroalkanethiol, preferably a perfluoroalkanethiol, such as 3,3,4,4,5,5,6,6,7,7,8,8,9,9, 10,10, 10-heptadecafluorodecane- 1 -thiol.
- fluorinating agents include perfluoroalkaneammes and amine and thiol benzyl subsititued perfluoroalkanes such as 3-perfluorooctylpropylamine, 4-methyl- 3,5-bis(perfluorohexyl)benzylthiol, 4-methyl-3,5-bis(perfluorohexyl)benzylamine.
- the photocatalyst is a fluorinated derivative of a photocatalyst examples preferably include organic non-polar sensitisers such as porphyrin, chlorin, or bacteriochlorin, phthalocyanine, fullerene (C 6 o).
- organic non-polar sensitisers such as porphyrin, chlorin, or bacteriochlorin, phthalocyanine, fullerene (C 6 o).
- Other embodiments use polar sensitisers with appropariate fluorinated ions, suitable examples include methylene blue, rose Bengal, Ru 2+ L 3 complexes, where L is any combination of bipyridine, bipyrazine, and 2,2- bipyrimidine and derivatives thereof.
- the a photocatalyst preferably include organic non-polar sensitisers such as porphyrin, chlorin, or bacteriochlorin, phthalocyanine, fullerene (C 6 o).
- Other embodiments use polar sensitiser
- a, b, c and d > 1 , preferably, from 1 to 16, more preferably, from 2 to 10, more preferably, 7; and m, n, o, p >1 , preferably, 1.
- Said preferred photocatalysts can be synthesised by reacting 5,10,15,20- tetrakis(pentafluorophenyl)porphyrin (TPFPP) with appropriate fluoroalkanethiols.
- a particularly preferred photocatalyst is
- Said particularly preferred photocatalyst can be synthesised by reacting 5,10,15,20- tetrakis(pentafluorophenyl)porphyrin (TPFPP) (available from Sigma Aldrich) with 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecane-l-thiol (Sigma Aldrich).
- TPFPP 5,10,15,20- tetrakis(pentafluorophenyl)porphyrin
- TPFPP tetrakis(pentafluorophenyl)porphyrin
- the reaction requires the presence of a secondary amine, preferably diethylamine (Sigma Aldrich).
- Preferred solvents for use in the reaction include
- the ethyl acetate and dimethylformamide are used in a volume to volume ratio of from about 5: 1 to about 1 :5; preferably from about 2: 1 to about 1 :2; preferably about 2: 1.
- the organic substrate may be any capable of being photo -oxidised or photo-oxygenated.
- Preferred organic substrates include tetrahydropyran and derivatives thereof.
- Particularly preferred organic substrates are precursors to artemisinin and derivatives thereof, including precursors to artesunate, dihydroartemisinin, artelinic acid, artenimol, arterolane and artemotil.
- Organic product may be any photo-oxidised or photo-oxygenated organic substrate.
- Preferred organic products include trioxane, and derivatives thereof, and in particular antimalarial trioxanes.
- Particularly preferred organic products are anti-malarial trioxanes selected from the group consisting of artemisinin, artesunate, dihydroartemisinin, artelinic acid, artenimol, arterolane and artemotil.
- Such organic products may be used alone, or in combination, in the treatment of malaria. They may also be used in combination with other anti-malarial active pharmaceutical ingredients (APIs) in the treatment of malaria.
- Other anti-malarial APIs suitable for use in combination with the above organic products include quinine, mefloquine, amodiaquine, lumefantrine, piperaquine.
- Suitable fluorous solvents include fluorocarbons and fluoroethers, preferably perfluorocarbons, perfluoroaromatics, hydrofluorocarbons, perfluorethers, and hydrofluoroethers.
- fluorous solvents do not include chlorofluorocarbons.
- Suitable perfluorocarbons include perfluorohexane, perfluoromethylcyclohexane, or perfluorodecalin.
- Suitable hydrofluoroethers include nonafluorobutyl methyl ether, sold under the trade name HFE-7100 by 3M, and HFE-7500, also available from the 3M. These solvents retain many of the fluorous characteristics of perfluorocarbons, but possess higher overall solvating power due to increased polarity relative to perfluorocarbons. They also have less ozone depletion potential due to their short atmospheric lifetime.
- Irradiating the mixture typically comprises exposing the mixture to light, which for the purposes of the invention typically includes infra-red, ultraviolet and visible light.
- the light has a wavelength of from about 170 nm to about 300 ⁇ ; preferably, from about 200 nm to about 2,500 nm; preferably from about 380 nm to about 760 nm.
- An appropriate light source will typically be selected depending on the wavelength and intensity of light required.
- the wavelength of light will typically be determined by choice of photocatalyst; the wavelength being that required for the photocatalyst to catalyse the photo -oxidation of the organic substrate.
- White light sources, as well as narrow band or single wavelength sources, may be used in the invention for irradiating the mixture.
- a filter may also be used to select the wavelength required.
- the light source may be any appropriate light source, although light emitting diodes (LEDs) are preferred because of their low energy consumption.
- TPFPP 5,10,15,20- tetrakis(pentafluorophenyl)porphyrin
- Fig. 2 shows the results. Fig. 2: (a) 10 MPa, multi-phase, (b) 11 MPa, multi-phase (c) 12 MPa, multi-phase, (d) 13 MPa, multi-phase, (e) 14 MPa, cloudy single phase, (f) 15 MPa, cloudy single phase, (g) 16 MPa, clear single phase, (h) 17 MPa, clear single phase, (i) 18 MPa, clear single phase.
- HFE-7500 is available from 3M.
- Fig. 3 and Fig. 4 show the results of the initial flow experiments for a-terpinene and citronellol respectively.
- Fig. 3 and Fig. 4 also include schematic representations of the phase behaviour results from Fig. 1 and Fig. 2 respectively.
- Fig. 5 shows a schematic of the photochemical reactor with continuous fluorous phase (i.e. F8/HFE-7500) recycling.
- C0 2 is delivered by a Jasco PU-1580-CO 2 pump, 0 2 is added using a Rheodyne dosage unit.
- the citronellol and F8/HFE-7500 are simultaneously pumped using two Jasco PU-980 HPLC pumps.
- Ml and M2 mixers; R: sapphire tube reactor; LEDs: light source; BPR: back-pressure regulator (Jasco BP-1580-81); C: glass condenser; F: glassware flask; S: ultrasonic bath to accelerate phase separation of the product and F8/HFE-7500.
- 12 mL of F8 in HFE-7500 were recycled for ca. 20 h, at a flow rate of 0.1 mLmin 1 .
- Citronellol (3) was pumped at 0.2 mLmin "1 ; pressure 18 MPa.
- Table 1 compares the photo -oxidation of citronellol with the fluorous biphasic system, HFE-7500/F8, with the continuous reaction with dimethylcarbonate (DMC) / TPFPP described in Angew. Chem. Int. Ed. Engl., 2009, 48, 5322.
- DMC dimethylcarbonate
- Table 1 Comparison between the F8/HFE-7500 recycle and the TPFPP/DMC single pass experiment for oxidation of citronellol over a period of 20 h.
- HFE-7500 As in the initial flow experiments, nearly half the HFE-7500 was vented with the C0 2 .
- the HFE-7500 could have been recovered from the C0 2 by using a more sophisticated separation device; however, for the purpose of the experiment, it was simpler to add more HFE-7500 at periodic intervals to maintain a reservoir volume of ca. 12 mL.
- a twentyfold reduction in the amount of photocatalyst needed to make a given amount of product represents a significant reduction in the material cost of such a process.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Electromagnetism (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Extraction Or Liquid Replacement (AREA)
Abstract
A method for photo -oxidising an organic substrate to form an organic product is disclosed comprising: a) mixing oxygen, a supercritical fluid, a photocatalyst, a liquid fluorous solvent and an organic substrate to form a mixture; and b) irradiating the mixture to form an organic product. Also disclosed is a method for separating a photocatalyst from an organic product comprising the steps of: a) providing a mixture comprising a supercritical fluid; an organic product; a fluorous solvent; a photocatalyst; and optionally an organic substrate and optionally oxygen; wherein the organic product, fluorous solvent, photocatalyst and optional organic substrate and optional oxygen are dissolved in the supercritical fluid; and b) reducing the pressure of the mixture to a pressure below the critical pressure of the supercritical fluid in order to form a gaseous phase.
Description
SEPARATION TECHNIQUE, PHOTO-OXIDATION OF ORGANIC SUBSTRATES, AND PHOTO CATALYSTS
Field of the Invention
The present invention relates to the photo-oxidation of organic substrates and, in particular, continuous photo-oxidation with singlet oxygen in a supercritical fluid, preferably supercritical carbon dioxide, by use of fluorous biphasic catalysis. The invention relates to methods of photo -oxidising organic substrates, separating photocatalysts from organic products, mixtures for use in photo-oxidation and methods of manufacturing photocatalysts, new photo-catalysts, and new uses thereof.
Background of the Invention Photochemically generated singlet oxygen, 'C^, can provide a clean and sustainable route to photo-oxidised compounds. In the current regulatory climate, however, difficulties arise in selecting suitable solvents for the scale-up of such photo-oxidations due to the highly reactive nature of !02. Traditionally, these reactions have been performed in chlorinated solvents, e.g. CCI4, chosen because of their non-flammability and the long lifetime of !02 in these solvents. Nowadays, such solvents are unacceptable for most commercial applications because of their toxicity and environment impact. Therefore new approaches are needed so that !02 can realise its full potential in the Green Chemistry tool-box.
Supercritical carbon dioxide, scC02, has been explored as an alternative solvent, enabling photo -oxidations to be conducted safely in a non-flammable and non-toxic solvent. J02 has a relatively long lifetime in scC02 and its reactions occur more rapidly than in traditional solvents because single phase supercritical conditions reduce mass transfer limitations.
Nevertheless, there are still problems because the high pressures of scC02 dictate that any commercially viable scale-up generally must involve continuous processes. The problems arise because !02 often requires the use of a photocatalyst. These photocatalysts can be immobilised but they and their support need to be stable under both irradiative and high pressure conditions.
Photocatalysts immobilised on a solid polymer support in continuous scC02 reactors are known. However, the catalyst lifetime is often found to be limited <10 hours by degradation of the polymer support, predominantly by plasticisation, under irradiation and supercritical conditions; which eventually blocks the reactor. Much more preferable would be the feeding of homogeneous catalysts continuously into the reactor but these catalysts are difficult to separate from the reaction products, which almost invariably are thermally sensitive if not potentially explosive. There is therefore a need for photocatalysts and methods for photo-oxidising, and in particular methods for photo -oxygenating, an organic substrate which are cheaper, more efficient, safer and more environmentally friendly than those known in the art.
The invention sets out to address these and other problems with the prior art.
Summary of the Invention
In a first aspect, the present invention provides a method for photo -oxidising an organic substrate to form an organic product. Typically, the method is a method for photo- oxygenating an organic substrate to form an organic product. Preferably, the method comprises the steps of: a) mixing oxygen, a supercritical fluid, a photocatalyst, a fluorous solvent and an organic substrate to form a mixture; and, preferably, b) irradiating the mixture to form an organic product. Typically, the supercritical fluid is supercritical carbon dioxide.
Such a method allows the homogenous photo-catalysis of organic substrates while addressing the problems with the prior art.
In an embodiment, following the irradiation step, the method further comprises the step of reducing the mixture pressure to below the critical pressure of the supercritical fluid to form a gaseous phase. Typically, in order to form the gaseous phase and liquid fluorous solvent. Preferably, the fluorous solvent is liquid at the critical point of the supercritical
fluid. Preferably, the fluorous solvent is liquid at pressures at or below the critical pressure of the supercritical fluid. Preferably, the fluorous solvent is liquid at standard temperature and pressure (i.e. 20 °C and an absolute pressure of 101.325 kPa). Typically, the gaseous phase is gaseous carbon dioxide. Typically, the pressure is lowered below the critical pressure of carbon dioxide, preferably to atmospheric pressure (i.e. 101.325 kPa). Typically, the temperature will be kept constant, although it is possible for the temperature to be raised or, more preferably, lowered, typically below the critical temperature of the supercritical fluid, typically to below the critical temperature of carbon dioxide, typically to room temperature (i.e. 20 °C). Preferably, the phase separation of the supercritical fluid and fluorous solvent is controlled by varying the pressure. Controlling the phase separation of the supercritical fluid and fluorous solvent using pressure, rather than relying on temperature modulated extraction techniques, is preferable because it is safer for this type of compound. In a further embodiment, following the step of reducing the mixture pressure to below the critical pressure of the supercritical fluid to form a gaseous phase, the method preferably comprises the step of separating the gaseous phase and fluorous solvent; typically, gaseous carbon dioxide and liquid fluorous solvent. This is typically followed by the step of separating the fluorous solvent from the organic product.
It has been found by the inventors that it is sufficiently easy to separate fluorous solvents from the gaseous phase, and in particular carbon dioxide, that the method can be used as part of a continuous homogenous catalysis reaction process in which the fluorous solvent and photo-catalyst are recycled. Pressure modulated separation of carbon dioxide and fluorous solvent is advantageous as it is safer than temperature modulated extraction methods.
In a still further embodiment, the organic product and liquid fluorous solvent are substantially immiscible and/or insoluble. Preferably, organic product and liquid fluorous solvent separate into distinct phases, preferably distinct liquid phases. Preferably, the fluorous solvent is denser than the organic product. Preferably, the organic product is more
polar than the fluorous solvent. By having some or all of these properties it is relatively simple to extract the fluorous solvent from the organic product.
In embodiments, the organic product may be diluted during the separation step using a non-fluorous solvent in order to lower the viscosity of the organic product. Suitable non- fluorous solvents include methanol. In embodiments, the fluorous solvent and organic product may be agitated in order to expedite separation, for instance by using an ultrasonic bath. In embodiments, the photocatalyst is soluble in the fluorous solvent. Preferably, the photocatalyst is preferentially soluble in the fluorous solvent over the organic product.
In a further embodiment, when the fluorous solvent is separated from the organic product, the fluorous solvent comprises photocatalyst from the mixture, preferably a majority of the photocatalyst from the mixture, preferably at least about 70 % of the photocatalyst from the mixture, preferably at least about 80 % of the photocatalyst from the mixture, more preferably substantially all of the photocatalyst.
By having some or all of these properties it is relatively simple to extract separate the photocatalyst from the organic product. Easy extraction of the photocatalyst is beneficial as because the photocatalyst often represents the most valuable component of the mixture.
Typically, the photocatalyst, organic substrate, organic product, and fluorous solvent are soluble in the supercritical fluid, preferably supercritical carbon dioxide.
In preferred embodiments, the fluorous solvent and the photocatalyst are recycled. This has the advantage of greatly reducing the amount of photocatalyst required to provide a given amount of organic product. Typically, any fluorous solvent lost when removing the gaseous carbon dioxide may be replaced. Preferably, substantially all of the fluorous solvent is recovered from the gaseous carbon dioxide, e.g. by distillation.
In preferred embodiments, the mixture is single phase, preferably a clear single phase. Preferably, the mixing step and/or irradiating steps are conducted at a pressure sufficient for the mixture to form a single phase, preferably a clear single phase. Typically, the pressure is at least about 7.38 MPa; preferably, at least about 14 MPa; more preferably, at least about 16 MPa. The skilled person would be able to select an appropriate preferred pressure by observing when the mixture transitions from a cloudy to a clear single phase and selecting a pressure above that of the transition. The pressure will be above the critical pressure of the supercritical fluid. The mixing and/or irradiating steps are conducted at a temperature above the critical temperature of the supercritical fluid. Typically, the temperature of the mixture is at least about 31.1 °C; preferably, at least about 40 °C; preferably, from about 31.1 °C to about 70 °C; preferably, from about 40 °C to about 60 °C, preferably about 55 °C.
In preferred embodiments, the photocatalyst is fluorophilic, preferably a fluorinated photocatalyst. Fluorinated photocatalysts are preferred as they show good solubility in supercritical fluids, in particular carbon dioxide, and fluorous solvents. Known photocatalysts may be fluorinated by reacting them with a fluorinating agent, for instance with a with a fluoroalkanethiol, preferably a perfluoroalkanethiol, such as 3 ,3 ,4,4,5 ,5 ,6,6,7,7,8,8,9,9, 10, 10, 10-heptadecafluorodecane- 1 -thiol. Other preferred fluorinating agents include perfluoroalkaneamines and amine and thiol benzyl subsititued perfluoroalkanes such as 3-perfluorooctylpropylamine, 4-methyl-3,5- bis(perfluorohexyl)benzylthiol, 4-methyl-3,5-bis(perfluorohexyl)benzylamine.
In embodiments, the photocatalyst is a fluorinated derivative of a photocatalyst; examples preferably include organic non-polar sensitisers such as porphyrin, chlorin, bacteriochlorin, phthalocyanine, or fullerene (C6o). Other embodiments use polar sensitisers with appropariate fluorinated ions, suitable examples include methylene blue, rose Bengal, Ru2+L3 complexes, where L is any combination of bipyridine, bipyrazine, and 2,2- bipyrimidine and derivatives thereof.
In embodiments, the photocatalyst is selected from the group consisting of non-polar organic sensitisers, typically porphyrins.
In a preferred embodiment, the a photocatalyst is
wherein a, b, c and d = > 1, preferably, from 1 to 16, more preferably, from 2 to 10, more preferably, 7; and m, n, o, p >1, preferably, 1.
Preferably, a = b = c = d. Preferably, m = n = o = p.
A particularly preferred photocatalyst is
In further embodiments, the organic substrate is selected from the group consisting of unsaturated hydrocarbons, preferably dienes (particularly alpha-terpinene), furans, highly substituted olefins (particularly tetra or tri substituted e.g. citronellol), allylic alcohols, carbonyl compounds.
In embodiments, the fluorous solvent is selected from the group consisting of fluorocarbons and fluoroethers and combinations thereof, preferably perfluorocarbons, hydro fluorocarbons, perfluoroaromatics, perfluorethers, and hydro fluoroethers.
Suitable perfluorocarbons include perfluorohexane, perfluoromethylcyclohexane, or perfluorodecalin.
Suitable hydro fluoroethers (HFEs) include HFE-7100 and HFE-7500 (both sold by 3M).
In a second aspect, the invention provides an organic product manufactured using any of the methods of the first aspect.
In a third aspect, the invention provides the use of the method of the first aspect in the manufacture of trioxane, and derivatives thereof, primarily hydroxyl substituted hydroperoxides preferentially possessing a hydroxyl group located 3-4 bonds from the peroxide, possibly 2-5 bonds.
In a fourth aspect, the invention provides a mixture comprising an organic substrate and/or an organic product; optionally oxygen; a supercritical fluid; a photocatalyst and a fluorous solvent. Preferably, the supercritical fluid is supercritical carbon dioxide. Typically, when there is no organic substrate in the mixture, the mixture will not comprise oxygen.
Typically, the mixture is single phase; preferably, the mixture is a clear single phase.
Typically, the mixture will transition from a multi-phase to a single-phase mixture by increasing the pressure of the mixture. Typically, the pressure is at least about 7.39 MPa; preferably, at least about 14 MPa; more preferably, at least about 16 MPa. The skilled person would be able to select an appropriate preferred pressure by observing when the
mixture transitions from a cloudy to a clear single phase. Typically, the temperature of the mixture is at least about 31.1 °C; preferably, at least about 40 °C; preferably, from about 31.1 °C to about 70 °C; preferably, from about 40 °C to about 60 °C, preferably about 55 °C.
The invention also provides the use of the mixture of the fourth aspect in the photo- oxidation, preferably photo-oxygenation, of an organic substrate.
The invention also provides the use of the mixture of the fourth aspect in a homogenous catalysis photo-oxidation reaction; preferably a homogenous catalysis photo-oxygenation reaction; preferably, wherein the photocatalyst is recycled.
The photocatalysts, fluorous solvents, organic products and organic substrates described in embodiments of the first aspect are also applicable to the second, third and fourth aspects of the invention.
In a fifth aspect, the present invention provides a photocatalyst
wherein a, b, c and d >1 ; preferably; from 1 tol6; preferably from 2 to 10; preferably, 7; and m, n, o and p >1 ; preferably, 1. When m = n = o = p = l and a = b = c = d, a≠ 9.
Preferably, a = b = c = d. Preferably, m = n = o = p.
A particularly preferred photocatalyst is
The invention also provides the use of the photocatalyst of the fifth aspect in homogenous catalysis.
The invention further provides the use of the photocatalyst of the fifth aspect of the invention in a photo -oxidation reaction, preferably, a photo-oxygenation reaction; preferably continuous homogenous catalysis photo-oxidation reaction, more preferably in a continuous homogenous catalysis photo-oxygenation reaction.
The invention also provides the use of the photocatalyst of the fifth aspect of the invention in any of the methods of the first aspect of the invention.
In a sixth aspect, the invention provides a method for manufacturing a photocatalyst according to the fifth aspect comprising the step of reacting 5,10,15,20- tetrakis(pentafluorophenyl)porphyrin (TPFPP) with a fluroalkanethiol, preferably, a perfluoroalkanethiol, preferably, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- heptadecafluorodecane-1 -thiol. In certain embodiments, a mixture of different
fluroalkanethiols may be used. Other preferred fluorinating agents include perfluoroalkaneamines and amine and thiol benzyl subsititued perfluoroalkanes such as 3- perfluorooctylpropylamine, 4-methyl-3,5-bis(perfluorohexyl)benzylthiol, 4-methyl-3,5- bis(perfluorohexyl)benzylamine.
In a seventh aspect, the invention provides a method for manufacturing a photocatalyst for use in the homogenous catalysis of an organic substrate comprising the steps of a) selecting a fluorous solvent; b) selecting a supercritical fluid; c) selecting a photocatalyst; and d) fluorinating the photocatalyst to such an extent that the fluorinated photocatalyst is soluble in both the fluorous solvent and the supercritical fluid.
Preferably, the supercritical fluid is supercritical carbon dioxide. The fluorous solvents, photocatalysts and organic substrates may be selected from any of those listed in relation to the previous aspects and embodiments of the invention. Preferably, the fluorinated photocatalyst is preferentially soluble in the fluorous solvent over the photo-oxidised organic substrate.
The invention also provides a photocatalyst manufactured according to the seventh aspect of the invention, and the use of said photocatalyst in the photo -oxidation of an organic substrate.
In an eighth aspect the invention provides a method for separating a photocatalyst from an organic product comprising the steps of: a) providing a mixture comprising a supercritical fluid; an organic product; a fluorous solvent; a photocatalyst; and optionally an organic substrate and optionally oxygen; wherein the organic product, fluorous solvent, photocatalyst and optional organic substrate and optional oxygen are dissolved in the supercritical fluid; and b) reducing the pressure of the mixture to a pressure below the critical pressure of the supercritical fluid in order to form a gaseous phase.
All aspects of the method of first aspect of the invention may be combined mutatis mutandis with the eighth aspect of the invention.
In all of the aspects and embodiments of the invention, photo -oxidation includes photo- oxygenation.
Brief Description of the Figures
The above-mentioned and other features, embodiments and aspects of this invention, and the manner of obtaining them, will become more apparent and the invention itself will be better understood by reference to the following description of embodiments of the invention taken in conjunction with the accompanying drawings, wherein:
Fig. 1 is a series of photographs showing the phase behaviour of a a-terpinene (6.4 mmol) + HFE-7500 (4.0 mmol) + C02 (0.24 mol) + N2 (12.5 mmol) system at 55 °C under different pressure. Fig. 2 is a series of photographs showing the phase behaviour a citronellol (5.5 mmol) + HFE-7500 (3.9 mmol) + C02 (0.24 mol) + N2 (12.5 mmol) system at 55 °C under different pressure.
Fig. 3 is a graph showing conversion / pressure for a a-terpinene (6.4 mmol) + HFE-7500 (4.0 mmol) + C02 (0.24 mol) + N2 (12.5 mmol) system at 55 °C under different pressure.
Fig. 4 is a graph showing conversion / pressure for a citronellol (5.5 mmol) + HFE-7500 (3.9 mmol) + C02 (0.24 mol) + N2 (12.5 mmol) system at 55 °C. Fig. 5 is a schematic of the continuous recycle experiment equipment.
Detailed Description of the Invention
The present invention provides a method for the photo-oxidation of an organic substrate to an organic product comprising the steps of: a) mixing oxygen, a supercritical fluid, a photocatalyst, a fluorous solvent and an organic substrate to form a mixture; and,
preferably, b) irradiating the mixture to form an organic product. Typically, the supercritical fluid is supercritical carbon dioxide.
Supercritical fluid is the fluid state of any substance at a temperature and pressure above its critical point, where distinct liquid and gas phases do not exist. Typically, supercritical fluids can effuse through solids like a gas, and dissolve materials like a liquid.
Suitable supercritical fluids for use in the invention include supercritical methane, ethane and carbon dioxide.
Supercritical carbon dioxide is a fluid state of carbon dioxide where it is held at or above its critical temperature and critical pressure. Specifically, carbon dioxide behaves as a supercritical fluid above its critical temperature of 31.1 °C and critical pressure of 7.38 MPa.
For the purpose of the invention, photo-oxidation is understood to be a light-induced oxidation reaction. Photo -oxidation includes photo-oxygenation.
For the purpose of the invention, photo-oxygenation is understood to be a light-induced oxidation reaction in which molecular oxygen is incorporated into organic substrate. Typically, the photo-oxygenation reactions of the invention use singlet oxygen (102).
Photocatalyst is understood to mean a catalyst which accelerates a photo-oxidation, preferably photo-oxygenation, reaction. Preferably, the photocatalyst is soluble in the fluorous solvent. Preferably, the photocatalyst is preferentially soluble in the liquid fluorous solvent over the organic product. Preferably, the photocatalyst is soluble in supercritical carbon dioxide. Relative solubility should be measured at standard temperature and pressure. Preferably, the photocatalyst is fluorophilic. Preferably the photocatalyst is fluorinated. Fluorinated photocatalysts are preferred as they show good solubility in supercritical carbon dioxide and fluorous solvents. Known photocatalysts may be fluorinated by
reacting them with a fluorinating agent, for instance a with a fluoroalkanethiol, preferably a perfluoroalkanethiol, such as 3,3,4,4,5,5,6,6,7,7,8,8,9,9, 10,10, 10-heptadecafluorodecane- 1 -thiol. Other preferred fluorinating agents include perfluoroalkaneammes and amine and thiol benzyl subsititued perfluoroalkanes such as 3-perfluorooctylpropylamine, 4-methyl- 3,5-bis(perfluorohexyl)benzylthiol, 4-methyl-3,5-bis(perfluorohexyl)benzylamine.
In embodiments, the photocatalyst is a fluorinated derivative of a photocatalyst examples preferably include organic non-polar sensitisers such as porphyrin, chlorin, or bacteriochlorin, phthalocyanine, fullerene (C6o). Other embodiments use polar sensitisers with appropariate fluorinated ions, suitable examples include methylene blue, rose Bengal, Ru2+L3 complexes, where L is any combination of bipyridine, bipyrazine, and 2,2- bipyrimidine and derivatives thereof. a preferred embodiment, the a photocatalyst
wherein a, b, c and d = > 1 , preferably, from 1 to 16, more preferably, from 2 to 10, more preferably, 7; and m, n, o, p >1 , preferably, 1.
Preferably, a = b = c = d. Preferably, m = n = o = p.
Said preferred photocatalysts can be synthesised by reacting 5,10,15,20- tetrakis(pentafluorophenyl)porphyrin (TPFPP) with appropriate fluoroalkanethiols.
A particularly preferred photocatalyst is
Said particularly preferred photocatalyst can be synthesised by reacting 5,10,15,20- tetrakis(pentafluorophenyl)porphyrin (TPFPP) (available from Sigma Aldrich) with 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecane-l-thiol (Sigma Aldrich). Typically, the reaction requires the presence of a secondary amine, preferably diethylamine (Sigma Aldrich). Preferred solvents for use in the reaction include ethyl acetate (Sigma Aldrich) and dimethylformamide (Sigma Aldrich), and combinations thereof. Other appropriated solvents will be apparent to the person skilled in the art. When used in combination, preferably the ethyl acetate and dimethylformamide are used in a volume to volume ratio of from about 5: 1 to about 1 :5; preferably from about 2: 1 to about 1 :2; preferably about 2: 1.
The organic substrate may be any capable of being photo -oxidised or photo-oxygenated. Preferred organic substrates include tetrahydropyran and derivatives thereof.
Particularly preferred organic substrates are precursors to artemisinin and derivatives thereof, including precursors to artesunate, dihydroartemisinin, artelinic acid, artenimol, arterolane and artemotil. Organic product may be any photo-oxidised or photo-oxygenated organic substrate.
Preferred organic products include trioxane, and derivatives thereof, and in particular antimalarial trioxanes. Particularly preferred organic products are anti-malarial trioxanes selected from the group consisting of artemisinin, artesunate, dihydroartemisinin, artelinic acid, artenimol, arterolane and artemotil. Such organic products may be used alone, or in combination, in the treatment of malaria. They may also be used in combination with other anti-malarial active pharmaceutical ingredients (APIs) in the treatment of malaria. Other anti-malarial APIs suitable for use in combination with the above organic products include quinine, mefloquine, amodiaquine, lumefantrine, piperaquine.
Suitable fluorous solvents include fluorocarbons and fluoroethers, preferably perfluorocarbons, perfluoroaromatics, hydrofluorocarbons, perfluorethers, and hydrofluoroethers. Preferably, fluorous solvents do not include chlorofluorocarbons.
Suitable perfluorocarbons include perfluorohexane, perfluoromethylcyclohexane, or perfluorodecalin. Suitable hydrofluoroethers (HFEs) include nonafluorobutyl methyl ether, sold under the trade name HFE-7100 by 3M, and HFE-7500, also available from the 3M. These solvents retain many of the fluorous characteristics of perfluorocarbons, but possess higher overall solvating power due to increased polarity relative to perfluorocarbons. They also have less ozone depletion potential due to their short atmospheric lifetime.
HFE-7500
Irradiating the mixture typically comprises exposing the mixture to light, which for the purposes of the invention typically includes infra-red, ultraviolet and visible light. Preferably, the light has a wavelength of from about 170 nm to about 300 μιη; preferably, from about 200 nm to about 2,500 nm; preferably from about 380 nm to about 760 nm. An appropriate light source will typically be selected depending on the wavelength and intensity of light required. The wavelength of light will typically be determined by choice of photocatalyst; the wavelength being that required for the photocatalyst to catalyse the photo -oxidation of the organic substrate. White light sources, as well as narrow band or single wavelength sources, may be used in the invention for irradiating the mixture. A filter may also be used to select the wavelength required. The light source may be any appropriate light source, although light emitting diodes (LEDs) are preferred because of their low energy consumption.
Examples
1. Synthesis of the photocatalyst
Scheme 1. Synthesis of F8
Highly fluorinated photo catalyst, referred to herein as F8, was synthesised following Scheme 1.
Specifically, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecane-l-thiol (325 mg, 0.68 mmol) (Sigma Aldrich) was dissolved in 15 mL ethyl acetate (Sigma Aldrich)/ dimethylformamide (DMF) (Sigma Aldrich) (2: 1 v/v) with diethylamine (DEA) (0.1 mL, 0.97 mmol) (Sigma Aldrich) under nitrogen. 5,10,15,20- tetrakis(pentafluorophenyl)porphyrin (TPFPP) (57.5 mg, 0.06 mmol) dissolved in 5 mL DMF was added to this solution. The resulting solution was stirred under nitrogen at room temperature for 8 hours. The solution underwent centrifugation (8000 x g) for 15 minutes. The solid was isolated by filtration, and re-dissolved in acetone and purified by silica gel chromatography using hexane / acetone (9: 1 v/v). The yield of F8 was 112 mg (0.04 mmol, 67%). The obtained F8 was characterised by 1H and 19F-NMR. 1H-NMR (CDC13 5% TFA) δ: -2.84 (broad s, 2H, pyrrole NH), 2.64 to 2.81 (m, 8H, 2Ή), 3.50 (t, 8H, 1 Ή), 8.94 (s, 8H, pyrrole βΗ). 19F-NMR: (CDC13 5% TFA) δ: -136.12 to -135.99 (m, 8F, Ar-o-F), - 133.69 to -133.56 (m, 8F, Ar-m-F), -126.18 to -126.08 (m, 8F, 3'F), -123.14 (m, 8F, 4'F), - 122.71 (m, 8F, 5'F), -121.68 to -121.61 (m, 24F, 6'-8'F), -113.86 to -113.75 (m, 8F, 9'F), - 80.83 to 80.76 (m, 12F, 10'F). This method can be modified to fluorinate alternative photocatalysts. Furthermore, the fluoroalkanethiol of the method can be varied in order to obtain photocatalysts with alternative fluorinated chains.
2. Phase behaviour
Phase behaviour of the a-terpinene (6.4 mmol) + HFE-7500 (4.0 mmol) + C02 (0.24 mol) + N2 (12.5 mmol) system was studied using a variable volume view cell. Molar ratios of all the components were chosen to mimic the continuous flow experiment described below. N2 has very similar properties to 02 in terms of phase behaviour under this condition, it is therefore an acceptable substitute for 02 and avoids any potential safety hazards associated with 02.
Fig. 1 contains photographs which show the phase behaviour of the above mixture at 55 °C under different pressure. Fig. 1 : (a) 10 Mpa, multi-phase, (b) 11 MPa, multi-phase (c) 12 MPa, multi-phase, (d) 13 MPa, cloudy single phase, (e) 14 MPa, cloudy single phase, (f) 15 MPa, cloudy single phase, (g) 16 MPa, clear single phase, (h) 17 MPa, clear single phase, (i) 18 MPa, clear single phase.
The phase behaviour of the citronellol (5.5 mmol) + HFE-7500 (3.9 mmol) + C02 (0.24 mol) + N2 (12.5 mmol) system at 55 °C under different pressure was also investigated. Fig. 2 shows the results. Fig. 2: (a) 10 MPa, multi-phase, (b) 11 MPa, multi-phase (c) 12 MPa, multi-phase, (d) 13 MPa, multi-phase, (e) 14 MPa, cloudy single phase, (f) 15 MPa, cloudy single phase, (g) 16 MPa, clear single phase, (h) 17 MPa, clear single phase, (i) 18 MPa, clear single phase. HFE-7500 is available from 3M.
HFE-7500
3. Initial Flow Experiments
(1 ) (2)
(3) (4) (5) Initial flow experiments investigated the effect of pressure on the reaction of a-terpinene (1) and the biphasic separation of the organic product (2). It was found that the reaction was single-phase at >14 MPa with >99 % conversion. Although ca. 50% of the HFE-7500 was vented with the gaseous C02, none of (2) was lost. The liquid HFE-7500 and (2) showed clear phase separation but some F8 remained in the (2). However, much of this F8 could be recovered from (2) by separating the layers, leaving them to stand, and then adding enough HFE-7500 to make up the loss during venting.
The continuous photo -oxidation of citronellol (3) was also investigated. A single phase system was observed at >16 MPa with >99%> conversion. As the product mixture was rather viscous but, (3), (4) and (5) are significantly more polar than either (ι) or (2), less F8 was left in the organic phase than with (2).
Fig. 3 and Fig. 4 show the results of the initial flow experiments for a-terpinene and citronellol respectively. Fig. 3 and Fig. 4 also include schematic representations of the phase behaviour results from Fig. 1 and Fig. 2 respectively.
4. Continuous Recycle Experiment
A fully continuous recycle of the F8/HFE-7500 was then carried out. F8/HFE-7500 and citronellol (3) were pumped separately and the fluorous phase (i.e. F8/HFE-7500) in the product flask acted as the reservoir for the F8/HFE-7500 pump. Methanol was added periodically to the product collection flask to lower the viscosity of the organic product and an aliquot of HFE-7500 was added each hour to replace the HFE-7500 lost during depressurisation. The flow rates were increased to force the conversion of (3) to around 50 % by decreasing the residence time while still maintaining a single phase in the reactor. Under these stressed conditions, the effect of recycling F8/HFE-7500 on the conversion during the reaction could be investigated.
Fig. 5 shows a schematic of the photochemical reactor with continuous fluorous phase (i.e. F8/HFE-7500) recycling. C02 is delivered by a Jasco PU-1580-CO2 pump, 02 is added using a Rheodyne dosage unit. The citronellol and F8/HFE-7500 are simultaneously pumped using two Jasco PU-980 HPLC pumps. Ml and M2: mixers; R: sapphire tube reactor; LEDs: light source; BPR: back-pressure regulator (Jasco BP-1580-81); C: glass condenser; F: glassware flask; S: ultrasonic bath to accelerate phase separation of the product and F8/HFE-7500. 12 mL of F8 in HFE-7500 were recycled for ca. 20 h, at a flow rate of 0.1 mLmin 1. Citronellol (3) was pumped at 0.2 mLmin"1; pressure 18 MPa.
Table 1 compares the photo -oxidation of citronellol with the fluorous biphasic system, HFE-7500/F8, with the continuous reaction with dimethylcarbonate (DMC) / TPFPP described in Angew. Chem. Int. Ed. Engl., 2009, 48, 5322. Bearing in mind that the F8/HFE-7500 experiment was deliberately run to give only 50% conversion, one can see that fluorous recycle reaction was considerably more efficient than the single pass DMC/TPFPP experiment, giving twice as much product with x lO fewer moles of photocatalyst.
Table 1 Comparison between the F8/HFE-7500 recycle and the TPFPP/DMC single pass experiment for oxidation of citronellol over a period of 20 h.
F8/HFE TPFPP/D
-7500 MCC
Amount of Citronellol 1.32 0.33 [60]
(mol [mL]) [240]
Conversion (%) 50 a 100
Yield of Products (4) + 0.66 0.33
(5) (mol)
Citronellol:PCd 5 000: 1 1 000: 1
(mohmol)
Apparent TONe 27 000 1 000
Amount of PC at Start 2.4 x 10" 2.5 x 10"4
5
(mol)
Amount of PC in HFE- 6.5 x 10" -
6
7500 at End (mol)
Total volume of HFE- 12 (+ -
7500 (mL) 100 )b
Recovery of F8 per 88 % -
Recycle
Recovery of HFE-7500 55 % - per Recycle a The conversion of (3) to its peroxides, (4) + (5), was forced to ca. 50 %.
b The amount of HFE-7500 added during the reaction to replace that lost with C02. (i.e. 20x5 mL)
c Dimethylcarbonate;
d PC, photocatalyst;
e TON, turnover number.
As in the initial flow experiments, nearly half the HFE-7500 was vented with the C02. The
HFE-7500 could have been recovered from the C02 by using a more sophisticated separation device; however, for the purpose of the experiment, it was simpler to add more HFE-7500 at periodic intervals to maintain a reservoir volume of ca. 12 mL.
A twentyfold reduction in the amount of photocatalyst needed to make a given amount of product represents a significant reduction in the material cost of such a process.
It will be appreciated by those skilled in the art that the foregoing is a description of a preferred embodiment of the present invention and that variations in design and construction may be made to the preferred embodiment without departing from the scope of the invention as defined by the appended claims.
Claims
1. A method for photo-oxidising an organic substrate to form an organic product comprising the steps of:
a) mixing oxygen, a supercritical fluid, a photocatalyst, a liquid fluorous solvent and an organic substrate to form a mixture; and
b) irradiating the mixture to form an organic product.
2. A method for separating a photocatalyst from an organic product comprising the steps of:
a) providing a mixture comprising a supercritical fluid; an organic product; a fluorous solvent; a photocatalyst; and optionally an organic substrate and optionally oxygen; wherein the organic product, fluorous solvent, photocatalyst and optional organic substrate and optional oxygen are dissolved in the supercritical fluid; and
b) reducing the pressure of the mixture to a pressure below the critical pressure of the supercritical fluid in order to form a gaseous phase.
3. The method according to claim 1 comprising the step of reducing the pressure of the mixture to a pressure below the critical pressure of the supercritical fluid in order to form a gaseous phase.
4. The method according to claims 2 or 3 comprising the step of separating the gaseous phase from the fluorous solvent.
5. The method according to claim 2, 3 or 4 comprising the step of separating the fluorous solvent from the organic product.
6. The method according to claim 5 wherein the fluorous solvent separated from the organic product comprises photocatalyst from the mixture, preferably a majority of the photocatalyst from the mixture.
7. The method according to any preceding claim wherein the organic product and fluorous solvent are substantially immiscible.
8. The method according to any preceding claim wherein the photocatalyst is soluble in the fluorous solvent.
9. The method according to any preceding claim wherein the photocatalyst is preferentially soluble in the fluorous solvent rather than the organic product.
10. The method according to any preceding claim wherein the photocatalyst, fluorous solvent, organic substrate and/or organic product are soluble in the supercritical fluid.
1 1. The method according to any preceding claim wherein the fluorous solvent and the photocatalyst are recycled.
12. The method according to any preceding claim wherein the mixture is single phase.
13. The method according to any preceding claim wherein the mixing step is conducted at a pressure sufficient for the mixture to form a single phase.
14. The method according to claim 13 wherein the pressure is at least 7.38 MPa.
15. The method according to any preceding claim wherein the photocatalyst is fluorinated.
16. The method according to any preceding claim wherein the photocatalyst is selected from the group consisting of fluorinated derivatives porphyrin, chlorin, bacteriochlorin, phthalocyanine, or fullerene (C6o) or fluorinated ions of methylene blue, rose Bengal, Ru2+L3 complexes, where L is any combination of bipyridine, bipyrazine, and 2,2- bipyrimidine and derivatives thereof.
17. The method according to any preceding claim wherein the organic substrate is selected from the group consisting of unsaturated hydrocarbons, preferably dienes (particularly alpha-terpinene), furans, highly substituted olefins (particularly tetra or tri substituted e.g. citronellol), allylic alcohols, carbonyl compounds, tetrahydropyran and derivatives thereof
18. The method according to any preceding claim wherein the fluorous solvent is selected from the group consisting of fluorocarbons and fluoroethers, preferably perfluorocarbons, hydrofluorocarbons, perfluoroaromatics, perfluorethers, and
hydro fluoroethers.
19. The method according to any preceding claim wherein the supercritical fluid is supercritical carbon dioxide.
20. An organic product manufactured using the method of any of claims 1 to 19.
21. The use of the method of claims 1 to 18 in the manufacture of trioxanes, and derivatives thereof, and in particular anti-malarial trioxanes
22. A mixture comprising an organic substrate and/or organic product; oxygen; a supercritical fluid; a photocatalyst and a fluorous solvent.
23. The mixture according to claim 22 wherein the mixture is single phase.
24. The mixture according to claims 22 or 23 wherein the supercritical fluid is supercritical carbon dioxide.
25. The use of the mixture of claims 22 to 24 in the photo -oxidation, preferably photo- oxygenation, of the organic substrate.
26. A photocatalyst having the structural formula
wherein a, b, c and d = from 0 to 8, preferably >1; preferably from 1 to 8; preferably from 2 to 8; preferably 7; and m, n, o and p >1; preferably = 1.
27. The use of the photocatalyst according to claim 26 as a homogeneous catalyst in a continuous photo-oxidation reaction, preferably a continuous photo-oxygenation reaction.
28. The use of the photocatalyst according to claim 26 in the methods of claims 1 to 19.
29. A method for manufacturing a photocatalyst comprising the step of reacting 5,10,15,20-tetrakis(pentafluorophenyl)porphyrin with a perfluoroalkanethiol, preferably, 3 ,3 ,4,4,5 ,5 ,6,6,7,7,8,8,9,9, 10, 10, 10-heptadecafluorodecane- 1 -thiol.
30. A method for manufacturing a photocatalyst for use in the homogenous catalysis of an organic substrate comprising the steps of:
a) selecting a fluorous solvent;
b) selecting a supercritical fluid;
c) selecting a photocatalyst; and
d) fluorinating the photocatalyst to such an extent that it is soluble in both the fluorous solvent and the supercritical fluid.
31. The method of claim 30 wherein the supercritical fluid is supercritical carbon dioxide.
32. A photocatalyst manufactured according to the method of claim 30 or 31.
33. The use of the photocatalyst according to claim 30 in the photo-oxidation of an organic substrate.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1119679.7A GB201119679D0 (en) | 2011-11-15 | 2011-11-15 | Separation technique |
| PCT/GB2012/052818 WO2013072678A1 (en) | 2011-11-15 | 2012-11-13 | Separation technique, photo-oxidation of organic substrates, and photo catalysts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP2780303A1 true EP2780303A1 (en) | 2014-09-24 |
Family
ID=45444148
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP12812308.0A Withdrawn EP2780303A1 (en) | 2011-11-15 | 2012-11-13 | Separation technique, photo-oxidation of organic substrates, and photo catalysts |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20140288328A1 (en) |
| EP (1) | EP2780303A1 (en) |
| CN (1) | CN104203874A (en) |
| AU (1) | AU2012338554A1 (en) |
| GB (1) | GB201119679D0 (en) |
| WO (1) | WO2013072678A1 (en) |
| ZA (1) | ZA201403143B (en) |
-
2011
- 2011-11-15 GB GBGB1119679.7A patent/GB201119679D0/en not_active Ceased
-
2012
- 2012-11-13 EP EP12812308.0A patent/EP2780303A1/en not_active Withdrawn
- 2012-11-13 US US14/358,578 patent/US20140288328A1/en not_active Abandoned
- 2012-11-13 CN CN201280056017.8A patent/CN104203874A/en active Pending
- 2012-11-13 WO PCT/GB2012/052818 patent/WO2013072678A1/en not_active Ceased
- 2012-11-13 AU AU2012338554A patent/AU2012338554A1/en not_active Abandoned
-
2014
- 2014-04-30 ZA ZA2014/03143A patent/ZA201403143B/en unknown
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2013072678A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104203874A (en) | 2014-12-10 |
| WO2013072678A1 (en) | 2013-05-23 |
| US20140288328A1 (en) | 2014-09-25 |
| ZA201403143B (en) | 2016-01-27 |
| AU2012338554A1 (en) | 2014-05-22 |
| GB201119679D0 (en) | 2011-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pan et al. | Batch and continuous-flow Huisgen 1, 3-dipolar cycloadditions with an amphiphilic resin-supported triazine-based polyethyleneamine dendrimer copper catalyst | |
| Wei et al. | Metal-free Visible-light-induced C–H/C–H Cross-Dehydrogenative-coupling of Quinoxalin-2 (H)-ones with Simple Ethers | |
| Parmar et al. | Cycloaddition of CO2 with an epoxide-bearing oxindole scaffold by a metal–organic framework-based heterogeneous catalyst under ambient conditions | |
| Shultz et al. | Synthesis of catalytically active porous organic polymers from metalloporphyrin building blocks | |
| Li et al. | A crystalline porous coordination polymer decorated with nitroxyl radicals catalyzes aerobic oxidation of alcohols | |
| Qian et al. | Clean and selective oxidation of alcohols catalyzed by ion-supported TEMPO in water | |
| Dong et al. | Metal-free oxidative coupling of benzylamines to imines under an oxygen atmosphere promoted using salicylic acid derivatives as organocatalysts | |
| Taylor et al. | Copper-catalyzed atom transfer radical addition (ATRA) and cyclization (ATRC) reactions in the presence of environmentally benign ascorbic acid as a reducing agent | |
| Nourmohammadi et al. | Magnetic nanocomposite of crosslinked chitosan with 4, 6-diacetylresorcinol for gold immobilization (Fe3O4@ CS/DAR-Au) as a catalyst for an efficient one-pot synthesis of propargylamine | |
| Hall et al. | Maximising the efficiency of continuous photo-oxidation with singlet oxygen in supercritical CO 2 by use of fluorous biphasic catalysis | |
| Tang et al. | Cascade processes with micellar reaction media: recent advances and future directions | |
| CN112961054B (en) | A kind of method of iron-catalyzed aromatic compound ethoxycarbonyl difluoromethylation | |
| Zhang et al. | Deal; photoredox catalysis for the cycloaddition reactions | |
| Bosica et al. | The KA2 coupling reaction under green, solventless, heterogeneous catalysis | |
| Zhu et al. | Facile synthesis of a fully fused, three-dimensional π-conjugated Archimedean cage with magnetically shielded cavity | |
| Jia et al. | Switchable ROS species regulation facilitates the selective oxidation of benzyl alcohols enabled by an organic photocatalyst | |
| Huang et al. | Metal-free coordination of porphyrin-based porous organic polymers for efficient photocatalytic oxidative coupling of amines under visible light | |
| Patil et al. | Magnetically recoverable silica-decorated ferromagnetic-nanoceria nanocatalysts and their use with O-and N-butyloxycarbonylation reaction via solvent-free condition | |
| Yang et al. | Recognition of “oxygen-/water-fueled” PET-RAFT protocol matched to covalent organic frameworks | |
| Abdullah et al. | Deep eutectic solvents (Reline) and Gold Nanoparticles Supported on Titanium Oxide (Au–TiO2) as New Catalysts for synthesis some substituted phenyl (substituted-3-phenyloxiran) methanone Enantioselective Peroxidation | |
| De Paula et al. | An immobilized imidazolyl manganese porphyrin for the oxidation of olefins | |
| Kishimoto et al. | A pH-responsive molecular capsule with an acridine shell: catch and release of large hydrophobic compounds | |
| Meireles et al. | Classical and green cyclohexane oxidation catalyzed by manganese porphyrins: Ethanol as solvent and axial ligand | |
| Borsato et al. | Catalysis within the self-assembled resorcin [4] arene hexamer | |
| Sombat et al. | Micellar Nanoreactors from Amphiphilic Copolymers for Thia-Michael Addition in Water |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20140509 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
| 18W | Application withdrawn |
Effective date: 20160212 |